MarketBeat | Real-Time Financial News and Analysis

Open Main Menu Open Sidebar

Halozyme Therapeutics Company Profile (NASDAQ:HALO)

Consensus Ratings for Halozyme Therapeutics (NASDAQ:HALO) (?)
Ratings Breakdown: 9 Buy Rating(s)
Consensus Rating:Buy (Score: 3.00)
Consensus Price Target: $21.88 (194.41% upside)

Analysts' Ratings History for Halozyme Therapeutics (NASDAQ:HALO)
Show:
DateFirmActionRatingPrice TargetActions
2/1/2016Canaccord GenuityInitiated CoverageBuy$10.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/26/2016Piper JaffrayReiterated RatingOverweight$24.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/4/2015Wells FargoInitiated CoverageOutperformView Rating Details  Tweet This Rating  Share This Rating on StockTwits
11/18/2015Citigroup Inc.Initiated CoverageBuy$25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/22/2015BarclaysInitiated CoverageOverweight -> Overweight$27.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2015Piper JaffrayReiterated RatingBuy$24.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
8/11/2015JMP SecuritiesReiterated RatingBuy$21.00 -> $22.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/22/2015JPMorgan Chase & Co.Boost Price TargetOverweight$20.00 -> $25.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/5/2015Piper JaffrayReiterated RatingOverweight$19.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/4/2015JMP SecuritiesBoost Price TargetBuy$17.00 -> $21.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
6/1/2015MLV & Co.Reiterated RatingBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/20/2015BMO Capital MarketsSet Price TargetBuy$26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/8/2015MLV & Co.Reiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015MLV & Co.Initiated CoverageBuy$20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
3/3/2015BMO Capital MarketsBoost Price TargetBuy$24.00 -> $26.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
2/18/2015MLV & Co.Boost Price TargetBuy$15.00 -> $20.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2015JPMorgan Chase & Co.Boost Price TargetOverweight$12.00 -> $16.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/8/2015Piper JaffrayBoost Price Target$17.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
1/2/2015MLV & Co.Initiated CoverageBuy$12.00 -> $15.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/24/2014MLV & Co.Initiated CoverageBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
12/9/2014JPMorgan Chase & Co.Lower Price TargetOverweight$13.00 -> $12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
9/15/2014Jefferies GroupReiterated RatingUnderperform$4.50 -> $5.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
7/11/2014JPMorgan Chase & Co.Initiated CoverageOverweight$13.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/15/2014Citigroup Inc.Initiated CoverageBuy$12.00View Rating Details  Tweet This Rating  Share This Rating on StockTwits
4/4/2014BMO Capital MarketsReiterated RatingBuyView Rating Details  Tweet This Rating  Share This Rating on StockTwits
(Data available from 2/12/2014 forward)
            As Featured by CNBC As Featured by The Wall Street Journal As Featured by MarketWatch As Featured by The Boston Globe As Featured by the American Association of Individual Investors As Featured by Seeking Alpha